These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 37740817)
1. NRF2 Suppression Enhances the Susceptibility of Pancreatic Cancer Cells, Miapaca-2 to Paclitaxel. Riazi-Tabrizi N; Khalaj-Kondori M; Safaei S; Amini M; Hassanian H; Maghsoudi M; Hasani S; Baradaran B Mol Biotechnol; 2024 Sep; 66(9):2441-2454. PubMed ID: 37740817 [TBL] [Abstract][Full Text] [Related]
2. Effects of ginsenoside Rh2 on growth and migration of pancreatic cancer cells. Tang XP; Tang GD; Fang CY; Liang ZH; Zhang LY World J Gastroenterol; 2013 Mar; 19(10):1582-92. PubMed ID: 23538603 [TBL] [Abstract][Full Text] [Related]
3. lncRNA PVT1 silencing inhibits gastric cancer cells' progression via enhancing chemosensitivity to paclitaxel. Naseri B; Farsad-Akhtar N; Mardi A; Baghbani E; Bornedeli S; Asadi M; Shanehbandi D Gene; 2025 Jan; 932():148900. PubMed ID: 39209180 [TBL] [Abstract][Full Text] [Related]
4. Co-targeting NRF2 potentially enhances the in vitro anticancer effects of paclitaxel in gastric cancer cells. Hasani S; Khalaj-Kondori M; Safaei S; Amini M; Riazi-Tabrizi N; Maghsoudi M; Baradaran B Discov Oncol; 2024 Sep; 15(1):424. PubMed ID: 39256224 [TBL] [Abstract][Full Text] [Related]
5. Novel strategies in HPV‑16‑related cervical cancer treatment: An in vitro study of combined siRNA-E5 with oxaliplatin and ifosfamide chemotherapy. Rasizadeh R; Shiri Aghbash P; Mokhtarzadeh A; Poortahmasebi V; Ahangar Oskouee M; Sadri Nahand J; Amini M; Zahra Bahojb Mahdavi S; Hossein Yari A; Bannazadeh Baghi H Gene; 2025 Jan; 932():148904. PubMed ID: 39218415 [TBL] [Abstract][Full Text] [Related]
6. A combination of paclitaxel and siRNA-mediated silencing of Stathmin inhibits growth and promotes apoptosis of nasopharyngeal carcinoma cells. Wu Y; Tang M; Wu Y; Weng X; Yang L; Xu W; Yi W; Gao J; Bode AM; Dong Z; Cao Y Cell Oncol (Dordr); 2014 Feb; 37(1):53-67. PubMed ID: 24306928 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of cancer cell growth in gemcitabine-resistant pancreatic carcinoma by mangiferin phytochemical involves induction of autophagy, endogenous ROS production, cell cycle disruption, mitochondrial mediated apoptosis and suppression of cancer cell migration and invasion. Yu L; Chen M; Zhang R; Jin Z J BUON; 2019; 24(4):1581-1586. PubMed ID: 31646812 [TBL] [Abstract][Full Text] [Related]
8. Investigating the effect of LncRNA DLGAP1-AS2 suppression on chemosensitivity of gastric cancer to chemotherapy. Azadi SS; Safaralizadeh R; Amini M; Hosseinpour Feizi MA; Abdolzadeh S; Najafi S; Bahojb Mahdavi SZ; Yari A; Narimanzadeh L; Baradaran B; Mokhtarzadeh AA Naunyn Schmiedebergs Arch Pharmacol; 2024 Oct; 397(10):7891-7903. PubMed ID: 38748228 [TBL] [Abstract][Full Text] [Related]
9. Induction of pancreatic cancer cell apoptosis, invasion, migration, and enhancement of chemotherapy sensitivity of gemcitabine, 5-FU, and oxaliplatin by hnRNP A2/B1 siRNA. Gu WJ; Liu HL Anticancer Drugs; 2013 Jul; 24(6):566-76. PubMed ID: 23525071 [TBL] [Abstract][Full Text] [Related]
10. Antitumor Effects of Glychionide-A Flavonoid in Human Pancreatic Carcinoma Cells Are Mediated by Activation of Apoptotic and Autophagic Pathways, Cell Cycle Arrest, and Disruption of Mitochondrial Membrane Potential. Yu L; Chen M; Zhang R; Xu T Med Sci Monit; 2019 Feb; 25():962-969. PubMed ID: 30712054 [TBL] [Abstract][Full Text] [Related]
11. CD133 suppression increases the sensitivity of prostate cancer cells to paclitaxel. Aghajani M; Mokhtarzadeh A; Aghebati-Maleki L; Mansoori B; Mohammadi A; Safaei S; Asadzadeh Z; Hajiasgharzadeh K; Khaze Shahgoli V; Baradaran B Mol Biol Rep; 2020 May; 47(5):3691-3703. PubMed ID: 32246247 [TBL] [Abstract][Full Text] [Related]
12. Genistein induced anticancer effects on pancreatic cancer cell lines involves mitochondrial apoptosis, G Bi YL; Min M; Shen W; Liu Y Phytomedicine; 2018 Jan; 39():10-16. PubMed ID: 29433670 [TBL] [Abstract][Full Text] [Related]
13. [Stellera chamaejasme against multidrug resistance of triple-negative breast cancer MDA-MB-231 cell through Nrf2]. Zeng R; Wang XX; Cui XH; Yang Q; Zhu XX; Wang YJ Zhongguo Zhong Yao Za Zhi; 2024 Apr; 49(8):2222-2229. PubMed ID: 38812237 [TBL] [Abstract][Full Text] [Related]
14. Suppression of autophagy enhances preferential toxicity of paclitaxel to folliculin-deficient renal cancer cells. Zhang Q; Si S; Schoen S; Chen J; Jin XB; Wu G J Exp Clin Cancer Res; 2013 Dec; 32(1):99. PubMed ID: 24305604 [TBL] [Abstract][Full Text] [Related]
15. Notch3-specific inhibition using siRNA knockdown or GSI sensitizes paclitaxel-resistant ovarian cancer cells. Kang H; Jeong JY; Song JY; Kim TH; Kim G; Huh JH; Kwon AY; Jung SG; An HJ Mol Carcinog; 2016 Jul; 55(7):1196-209. PubMed ID: 26207830 [TBL] [Abstract][Full Text] [Related]
16. Silencing Wnt2B by siRNA interference inhibits metastasis and enhances chemotherapy sensitivity in ovarian cancer. Wang H; Fan L; Xia X; Rao Y; Ma Q; Yang J; Lu Y; Wang C; Ma D; Huang X Int J Gynecol Cancer; 2012 Jun; 22(5):755-61. PubMed ID: 22635028 [TBL] [Abstract][Full Text] [Related]
17. siRNA-mediated silencing of Nanog reduces stemness properties and increases the sensitivity of HepG2 cells to cisplatin. Alemohammad H; Motafakkerazad R; Asadzadeh Z; Farsad N; Hemmat N; Najafzadeh B; Vasefifar P; Baradaran B Gene; 2022 May; 821():146333. PubMed ID: 35182674 [TBL] [Abstract][Full Text] [Related]
18. LINC00511 knockdown prevents cervical cancer cell proliferation and reduces resistance to paclitaxel. Mao BD; Xu P; Xu P; Zhong Y; Ding WW; Meng QZ J Biosci; 2019 Jun; 44(2):. PubMed ID: 31180057 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of cyclin D1 promotes tumor cell growth and confers resistance to cisplatin-mediated apoptosis in an elastase-myc transgene-expressing pancreatic tumor cell line. Biliran H; Wang Y; Banerjee S; Xu H; Heng H; Thakur A; Bollig A; Sarkar FH; Liao JD Clin Cancer Res; 2005 Aug; 11(16):6075-86. PubMed ID: 16115953 [TBL] [Abstract][Full Text] [Related]
20. Nrf2-induced antiapoptotic Bcl-xL protein enhances cell survival and drug resistance. Niture SK; Jaiswal AK Free Radic Biol Med; 2013 Apr; 57():119-31. PubMed ID: 23275004 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]